You are here

Article metrics

Article menu

Download PDFPDF

Review Article
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019220
Jan 202020201
Feb 202044446
Mar 202058589
Apr 2020949413
May 202072725
Jun 2020515123
Jul 2020393915
Aug 2020313112
Sep 202062627
Oct 2020868619
Nov 2020929318
Dec 202010010018
Jan 2021989824
Feb 202111211322
Mar 202115715744
Apr 202111011038
May 202111511536
Jun 202110510520
Jul 2021717120
Aug 2021464610
Sep 2021757524
Oct 202112112151
Nov 202110710634
Dec 202110210225
Jan 202214114928
Feb 20229810028
Mar 202214315326
Apr 202212412831
May 202217117338
Jun 202212914037
Jul 202210010427
Aug 202213713728
Sep 202214214521
Oct 202210811020
Nov 202212112532
Dec 202210110213
Jan 202314014123
Feb 2023929220
Mar 202314114331
Apr 2023377379116
May 20239810029
Jun 202385859
Jul 2023909118
Aug 202313513626
Sep 2023888922
Oct 202310310515
Nov 202313213520
Dec 2023878714
Jan 2024606213
Feb 2024808118
Mar 202412312730
Apr 202411912127
May 2024646415
Jun 2024767620
Jul 202412312415
Aug 2024959218
Sep 2024707015
Oct 202413213230
Nov 2024798213
Dec 202411311315
Jan 2025999918
Feb 202525225229
Mar 2025858526
Apr 202511411420
May 2025858515
Jun 202519419411
Jul 2025110
Total701770941514